Aliada Therapeutics is a biotechnology company that focuses on therapeutics and delivery technology. It develops the Modular Delivery (MODEL) platform, a blood-brain barrier (BBB) crossing platform to facilitate drug delivery across central nervous system (CNS) diseases.